Retatrutide

Overview

Retatrutide is a first-in-class triple hormone receptor agonist designed for advanced research applications. This peptide targets three pivotal receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon. By simultaneously engaging these receptors, Retatrutide offers a unique approach to metabolic research, providing insights that aren’t achievable with single- or dual-agonist peptides.

Key Features

• Activates GLP-1, GIP, and glucagon receptors.
• Available in multiple dosages: 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, and 60 mg.
• Each pack contains 10 vials.
• ≥99% purity guaranteed.
• Designed for advanced metabolic research.

Specifications

FAQ

What is Retatrutide used for?

Retatrutide is primarily used for research purposes in metabolic studies, targeting multiple hormone receptors to assess their combined effects.

How should Retatrutide be stored?

Store in a cool, dry place, away from direct sunlight. Ensure the vials are sealed until use to maintain integrity.

Is Retatrutide suitable for human consumption?

Retatrutide is for research purposes only and is not intended for human consumption or medical use.

Related Products

• Cagrilintide
• Semaglutide
• Tirzepatide

Browse more in GLP-1 & Weight Loss Peptides.

Always read the label and use products as directed. Consult a qualified professional where appropriate.